Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer

Mee Sook Roh, Hyoun Wook Lee, Sang Bong Jung, Kyungeun Kim, Eun Hee Lee, Moon il Park, Jae Seok Lee, Mee Seon Kim

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


MicroRNA-200c (miR-200c) is known to play a pivotal role in the regulation of epithelial-to-mesenchymal and mesenchymal-to-epithelial transition processes. However, the biological function of miR-200c in human carcinogenesis remains controversial. We examined the association of miR-200c expression with various clinicopathological factors, including KRAS mutation status and survival, in patients with colorectal cancer (CRC). The expression level of miR-200c was evaluated in 109 paired CRC and normal tissue samples using quantitative reverse transcription polymerase chain reaction. The KRAS mutation status of the CRC samples was determined using the PNAClamp™ KRAS Mutation Detection kit. Compared with the normal tissue group, miR-200c expression was significantly upregulated in the CRCs (P <.001). The expression of miR-200c was increased in CRCs with higher grade (P =.009), advanced stage (P =.042), and lymphovascular invasion (P =.003). Thirty-one CRCs (28.4%) had KRAS mutations in codon 12 or 13. CRCs with KRAS mutations had significantly higher miR-200c expression than CRCs with wild-type KRAS (P =.003). In survival analysis, high miR-200c expression was correlated with worse overall survival (P =.017) and recurrence-free survival (P =.048). Our results indicate that miR-200c is involved in tumor progression and aggressiveness in CRCs, and this oncogenic role of miR-200c may be triggered by activation of the KRAS signaling pathway.

Original languageEnglish
Pages (from-to)350-355
Number of pages6
JournalPathology Research and Practice
Issue number3
StatePublished - Mar 2018


  • Colorectal cancer
  • KRAS mutation
  • MicroRNA
  • miR-200c
  • Prognosis


Dive into the research topics of 'Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer'. Together they form a unique fingerprint.

Cite this